MedPath

Maternal Opthalmic blood flow is used as a predictor of severe pregnancy induced hypertension.

Not Applicable
Conditions
Health Condition 1: O149- Unspecified pre-eclampsia
Registration Number
CTRI/2024/03/064446
Lead Sponsor
Sagarika N Swamyself
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.singleton live gestation

2.Gestational age between 19 to 23+0 weeks

3.After obtaining informed written consent

Exclusion Criteria

1.Chronic hypertensive and gestational hypertension

2.Diagnosed congenital anomalies

3.Known case of Cardiac diseases

4.Known case of thromboembolic disorders on T.Ecospirin

5.Ocular conditions like infections,trauma ,tumors

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To examine the potential value of opthalmic artery Doppler at 19 to 23weeksTimepoint: To examine the potential value of opthalmic artery Doppler at 19 to 23weeks
Secondary Outcome Measures
NameTimeMethod
To reduce the maternal morbidity and decide the plan of managementTimepoint: 19 to 23 weeks
© Copyright 2025. All Rights Reserved by MedPath